EQL Pharma AB (FRA:7JK) Days Sales Outstanding : 68.77 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB Days Sales Outstanding?

EQL Pharma AB's average Accounts Receivable for the three months ended in Mar. 2024 was €5.20 Mil. EQL Pharma AB's Revenue for the three months ended in Mar. 2024 was €6.90 Mil. Hence, EQL Pharma AB's Days Sales Outstanding for the three months ended in Mar. 2024 was 68.77.

The historical rank and industry rank for EQL Pharma AB's Days Sales Outstanding or its related term are showing as below:

FRA:7JK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 24.91 Med: 74.69 Max: 92.11
Current: 71.22

During the past 12 years, EQL Pharma AB's highest Days Sales Outstanding was 92.11. The lowest was 24.91. And the median was 74.69.

FRA:7JK's Days Sales Outstanding is ranked better than
50.6% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs FRA:7JK: 71.22

EQL Pharma AB's Days Sales Outstanding declined from Mar. 2023 (100.47) to Mar. 2024 (68.77).

EQL Pharma AB Days Sales Outstanding Historical Data

The historical data trend for EQL Pharma AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Days Sales Outstanding Chart

EQL Pharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

74.41

38.56

25.26

61.79

76.34

EQL Pharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															100.47	80.28	68.57	65.10	68.77

Competitive Comparison of EQL Pharma AB's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EQL Pharma AB's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's Days Sales Outstanding falls into.

EQL Pharma AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

EQL Pharma AB's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (4.609	+	5.155)	/	2 )	/	23.343	*	365
=	4.882					/	23.343	*	365
=	76.34

EQL Pharma AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (5.251	+	5.155)	/	2 )	/	6.904	*	365 / 4
=	5.203					/	6.904	*	365 / 4
=	68.77

EQL Pharma AB (FRA:7JK) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

EQL Pharma AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

EQL Pharma AB (FRA:7JK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

EQL:Sweden

Address

Stortorget 1, 3rd Floor, Lund, SWE, 222 23

Website

http://www.eqlpharma.com

EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines